Efamol® Evening Primrose Oil
Natural health product licensed in Canada
- Other names
- Efamol® Beautiful Skin Evening Primrose oil, Efamol® Pure Evening Primrose Oil, Efamol® Pure Evening Primrose Oil with Vitamin E
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80141432
- Status
- Active licence
- Licence date
- 2 June 2025
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : d-alpha tocophérol | 15 UI | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 10 mg AT | Not calculated |
| Oenothera biennis Source : Oenothera biennis - Graine Potency : 600 mg Linoleic acid | Not specified | Not calculated |
Non-medicinal ingredients
Huile de tournesol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1.5 mL ; maximum: 2 mL | 2 Tous les jours |
| Adolescentes | minimum: 12 years ; maximum: 17 years | minimum: 1.5 mL ; maximum: 2 mL | 2 Tous les jours |
| Enfants | minimum: 1 year ; maximum: 11 years | minimum: 1 mL ; maximum: 1.5 mL | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the treatment of dry, itchy skin caused by Atopic Eczema (dermatitis). Clinically shown to treat dry and itchy skin caused by Atopic Eczema (dermatitis). Source of an antioxidant for the maintenance of good health. Helps to improve biophysical skin properties including transepidermal water loss, skin moisture, elasticity, firmness and roughness. Clinically shown to help improve biophysical skin properties including transepidermal water loss, skin moisture, elasticity, firmness and roughness. Clinically shown to reduce transepidermal water loss. Improves skin hydration. Clinically shown to improve skin hydration. Reduces skin roughness. Clinically shown to reduce skin roughness. Clinically shown to improve skin hydration and reduce skin roughness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80141432
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.